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CHAPTER 1 
INTRODUCTION 
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1. BACKGROUND 
                      Gallstones are the most common biliary pathology, can be divided into 
three main types: cholesterol, pigment (black, brown) or mixed stones. In the USA 
and Europe, 80%cholesterol or mixed stones, where as in Asia, 80% are pigment 
stones. Cholesterol or mixed stones contain 51 – 99 % cholesterol plus admixture of 
calcium salts, bile acids, bile pigment and phospholipids. Gallstones may be single or 
multiple, large or small those containing calcium salts are radio-opaque. Single stones 
are uncommon but usually consist mainly of cholesterol and arise due to a disorder of 
the physio-chemical equilibrium which normally maintains cholesterol in micellar 
form in the bile. 
 
               Many studies were done to identify risk factor for biliary lithiasis in the west 
have focused on hypersaturation of cholesterol in bile in nucleation process a critical 
step in the genesis of bile stone. 
 
          Thyroid disorder is a prevalent condition among adult population; however, it is 
frequently over looked. For decade, there has been a discussion, whether thyroid 
disorders could cause gallstone disease. Particularly, there are several explanations for 
a possible relation between hypothyroidism and gallstone disease; these explanations 
include the known link between thyroid failure and disturbances of lipid metabolism 
11 
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1.2 OBJECTIVES 
The purpose of this study is 
1. To study the prevalence of hypothyroidism in patients presenting with 
CHOLELITHIASIS/ CHOLEDHOCOLITHIASIS. 
2. To assess if thyroid profile is indicated in patients with biliary lithiasis. 
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2.1 Anatomy of the biliary system 
“The biliary tree consists of the system of vessels and ducts which collect and deliver 
bile from the liver parenchyma to the second part of the duodenum. It is 
conventionally divided into intrahepatic and extrahepatic biliary trees. The 
intrahepatic ducts are formed from the larger bile canaliculi which join together to 
form segmental ducts. These fuse close to the porta hepatis into right and left hepatic 
ducts. The extrahepatic biliary tree consists of the right and left hepatic ducts, the 
common hepatic duct, the cystic duct and gallbladder and the common bile duct.” 
GALLBLADDER 
                 “The gallbladder is a flask-shaped; blind-ending diverticulum attached to 
the common bile duct by the cystic duct. It usually lies attached to the inferior surface 
of the right lobe of the liver, by connective tissue. In the adult the gallbladder is 
between 7 and 10 cm long, with a capacity of up to 50 ml. It can hold up to 500ml of 
bile. It usually lies in a shallow fossa in the liver parenchyma, covered by peritoneum 
continued from the liver surface. This attachment can vary widely. At one extreme, 
the gallbladder may be almost completely buried within the liver surface, having no 
peritoneal covering (intraparenchymal pattern); at the other extreme, it may hang from 
a short mesentery formed by the two layers of peritoneum separated only by 
connective tissue and a few small vessels (mesenteric pattern). 
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                                 The gallbladder varies in size and shape. The fundus may be 
elongated and highly mobile. Rarely, the fundus is folded back upon the body of the 
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gallbladder, the so-called Phrygian cap: on ultrasound, this may be wrongly 
interpreted as an apparent septum within an otherwise normal gallbladder. Again, 
rarely, the gallbladder may be bifid or completely duplicated, usually with a 
duplicated cystic duct 
 
Fig 1. Overall arrangement of the intrahepatic and 
extrahepatic biliary tree.  
 
CYSTIC DUCT 
                             The cystic duct is about 3-4 cms in length and it drains into the 
CBD. It   passes posteriorly to the left from the neck of the gallbladder, and joins the 
common hepatic duct to form the common bile duct. It almost always runs parallel to, 
and is adherent to, the common hepatic duct for a short distance before joining it. The 
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junction usually occurs near the porta hepatis but may be lower down in the free edge 
of the lesser omentum.  
 
Fig 2: Anatomical variations in cystic duct 
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                       Mucosa of the cystic duct has 5–12 crescentic folds; continuous with 
the neck of the gallbladder. They project obliquely in regular succession; appearing to 
form a spiral valve when the duct is cut in longitudinal section. When the duct is 
distended, the spaces dilate and it appears twisted like neck of the GB. 
HEPATIC BILE DUCTS 
                          The main right and left hepatic ducts; emerge from the liver and unite 
near the right end of the porta hepatis as the common hepatic duct. The extrahepatic 
right duct, is short and nearly vertical while the left, is more horizontal and lies in 
segment IV. The common hepatic duct is joined on its right in an acute angle by the 
cystic duct to form the CBD. “The common hepatic duct lies to the right of the hepatic 
artery and anterior to the portal vein in the free edge of the lesser omentum. 
COMMON BILE DUCT  
                               The common bile duct is formed near the porta hepatis, by the 
junction of the cystic and common hepatic ducts, and is usually between 6 and 8 cm 
long. Its diameter tends to increase somewhat with age but is usually around 6 mm in 
adults. It descends posteriorly and slightly to the left, anterior to the epiploic foramen, 
in the right border of the lesser omentum, where it lies anterior and to the right of the 
portal vein and to the right of the hepatic artery. It passes behind the first part of the 
duodenum with the gastroduodenal artery on its left, and then runs in a groove on the 
superolateral part of the posterior surface of the head of the pancreas.” The IVC lies 
posterior to the duct and the duct is occasionally embedded in the pancreatic tissue. It 
may lie close to the medial wall of the second part of the duodenum or as much as 2 
18 
 
cm from it: even when it is embedded in the pancreas, a groove in the gland marking 
its position can be palpated behind the second part of the duodenum. 
Calot's triangle 
                          The near triangular space, formed between the cystic duct, the 
common hepatic duct and the inferior surface of segment V of the liver, is commonly 
referred to as Calot's triangle. It is enclosed by the double layer of peritoneum, which 
forms the short mesentery of the cystic duct. Since the two layers are not closely 
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opposed, there is an appreciable amount of loose connective tissue within the triangle. 
It is perhaps better described as a pyramidal ‘space' with one apex lying at the junction 
of the cystic duct and fundus of the gallbladder, one at the porta hepatis, and two 
closer apices at the attachments of the gallbladder to the liver bed. The base of the 
triangle, thus lies on the inferior surface of the liver. This space usually contains the 
cystic artery as it approaches the gallbladder, the cystic lymph node and lymphatics 
from the gallbladder, one or two small cystic veins, the autonomic nerves running to 
the gallbladder, and some loose adipose tissue. It may contain any accessory ducts 
which drain into the gallbladder from the liver. One must be aware of the variations in 
cystic duct anatomy so that we avoid accidently ligating the common bile duct. 
 
Fig3: Normal anatomy of the cystic artery 
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VASCULAR SUPPLY AND LYMPHATIC DRAINAGE 
Cystic artery 
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These fine branches form a network which anastomoses with the vessels ascending 
around the common bile duct “and with the vessels from the liver parenchyma which 
descend with the right and left hepatic ducts. 
Ductal arteries 
                           The common bile duct and hepatic ducts are supplied by a fine 
network of vessels, which usually receive contributions from several sources; and 
which lie in close proximity to the ducts.” Disruption of the network during surgical 
exposure of the bile ducts over a long length frequently causes chronic ischaemia and 
resultant stenosis of the duct. Approaches which spare the network are necessary to 
avoid this complication.The common bile duct is fairly consistently supplied by two to 
four ascending and descending arteries which form long narrow anastomotic channels 
along the length of the duct: the most prominent of these are disposed into medial and 
lateral ‘trunks', although they may lie more anterolateral and posteromedial. The 
largest contributions, usually arise as one or two branches, from the retroduodenal 
branch of the gastroduodenal artery; as it crosses the anterior surface of the duct at the 
upper border of the duodenum. Three or four descending branches; supply this 
network from the right hepatic and cystic arteries; as these vessels pass close to the 
lower common hepatic duct, occasionally they are “the dominant supply to the 
common bile duct”. 
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                           Posteriorly, a retroportal artery often arises from the coeliac axis, 
superior mesenteric artery or one of their major branches close to the origin from the “
 
 Lymphatics:                       
         Numerous lymphatic vessels; run from the submucosal and subserosal plexuses 
on all aspects of the gallbladder and cystic duct. Those on the hepatic aspect of the 
gallbladder connect with the intrahepatic lymph vessels. “The remainder drain into the 
cystic node, which usually lies above the cystic duct in the tissue of Calot's triangle. 
This node, and some lymphatic channels which bypass the cystic node, drain into a 
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node lying in the anterior border of the free edge of the lesser omentum. Hepatic 
nodes collect lymph from vessels that accompany the hepatic ducts and the upper” 
part of the bile duct. The inferior hepatic and upper pancreaticosplenic nodes receive 
lymphatics from the lower part of Common bile duct. 
INNERVATION 
                            The gallbladder and the extrahepatic biliary tree are innervated by 
branches from the hepatic plexus. The retroduodenal part of the common bile duct and 
the smooth muscle of the hepatopancreatic ampulla are also innervated by twigs from 
the pyloric branches of the vagi. 
 
                           Referred pain: In common with other structures of foregut origin, 
pain caused by stretch of the common bile duct or gallbladder is referred to the 
epigastrium. Involvement of the overlying somatic peritoneum produces pain which is 
more localized to the right upper quadrant. 
GALLBLADDER 
                                    The fundus of the gallbladder is completely covered by a 
serosa, and the inferior surfaces and sides of the body and neck of the gallbladder are 
usually covered by a serosa. If the gallbladder possesses a mesentery the serosa 
extends around the sides of the body and neck onto the superior surface and continues 
into the serosa of the mesentery, whereas the serosa is limited to the inferior surfaces 
only if the gallbladder is intrahepatic. Beneath the serosa is subserous loose 
connective and adipose peritoneal tissue. The gallbladder wall microstructure 
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generally resembles that of the small intestine. The mucosa is yellowish-brown and 
elevated into minute rugae with a honeycomb appearance. In section, projections of 
the mucosa into the gallbladder lumen resemble intestinal villi, but they are not fixed 
structures and the surface flattens as the gallbladder fills with bile. The epithelium is a 
single layer of columnar cells with apical microvilli; basally, the spaces between 
epithelial cells are dilated. Many capillaries lie beneath the basement membrane. The 
epithelial cells actively absorb water and solutes from the bile and concentrate it up to 
ten-fold. There are no goblet cells in the epithelium. The thin fibromuscular layer is 
composed of fibrous tissue mixed with smooth muscle cells arranged loosely in 
longitudinal, circular and oblique bundles. Gall bladder does not have submucosal 
layer and a muscular layer. 
BILE DUCTS 
                     The walls of the large biliary ducts consist of external fibrous and 
internal mucosal layers. The outer layer is fibrous connective tissue containing a 
variable amount of longitudinal, oblique and circular smooth muscle cells. The 
mucosa is continuous with that in the hepatic ducts, gallbladder and duodenum. The 
epithelium is columnar and there are numerous tubuloalveolar mucous glands in the 
duct walls. 
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     Fig 4: Low 
power micrograph showing the gallbladder wall and the human common bile duct structure. 
 
 
Sphincter of Oddi: 
                                  The sphincter of Oddi regulates flow of bile; into the duodenum, 
prevents the regurgitation of duodenal contents into the biliary tree, and diverts bile 
into the gallbladder. It is a “complex structure that is functionally independent from 
the duodenal musculature and creates a high-pressure zone between the bile duct and 
the duodenum.  
 
                           The sphincter of Oddi is about 4 to 6 mm in length and has a basal 
resting pressure of about 13 mmHg above the duodenal pressure. On manometry, the 
sphincter shows phasic contractions with a frequency of about four per minute and 
amplitude of 12 to 140 mmHg. The spontaneous motility of the sphincter of Oddi is 
regulated by the interstitial cells of Cajal through intrinsic and extrinsic inputs from 
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hormones and neurons acting on the smooth muscle cells. Relaxation occurs with a 
rise in CCK, leading to diminished amplitude of phasic contractions and reduced basal 
pressure, allowing increased flow of bile into the duodenum. During fasting, the 
sphincter of Oddi activity is coordinated with the periodic partial gallbladder 
emptying and an increase in” bile flow; that occurs during phase II of  migrating 
myoelectric motor complex. 
2.2 Physiology of biliary system 
BILE: 
                        The amount of bile secreted per day is 500- 1000ml. Bile serves two 
important “functions: First, bile plays an important role in fat digestion and 
absorption, because bile acids in the bile do two things: 
(1) Bile emulsifies fat into smaller particles which can be attacked by lipase enzyme 
secreted from the pancreas 
(2) They aid in absorption of the digested fat end products through the intestinal 
mucosal membrane. 
                     Second, bile serves as a means for excretion of several important waste 
products from the blood.” These include especially “bilirubin”, an end product of 
haemoglobin degradation; and excesses of cholesterol. 
SECRETION OF BILE: 
                         Bile is secreted in two stages by the liver:  
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 STORAGE OF BILE: 
                               Bile is normally stored in the gallbladder until required in the 
duodenum. The maximum volume that it can hold - 30 to 60 milliliters. Nevertheless, 
as “ much as 12 hours of bile secretion (usually about 450 milliliters) can be stored in 
the gallbladder because water, sodium, chloride, and most other small electrolytes are 
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continually absorbed through the gallbladder mucosa, concentrating the remaining bile 
constituents that contain the bile salts, cholesterol, lecithin, and bilirubin. 
 
                        Most of this gallbladder absorption is caused by active transport of 
sodium through the gallbladder epithelium, and this is followed by secondary 
absorption of chloride ions, water, and most other diffusible constituents. Bile is 
normally concentrated in this way about 5-fold, but it can be concentrated up to a 
maximum of 20-fold. 
 Comparison of Hepatic Duct Bile and Gallbladder Bile. 
 
 
 Hepatic Duct Bile Gallbladder Bile 
Percentage of solids 2–4 10–12 
Bile acids (mmol/L) 10–20 50–200 
pH 7.8–8.6 7.0–7.4 
 
                                     
                        This table shows that gall bladder bile has more solutes which are 
mainly the bile salts. Also secreted or excreted in large concentrations are bilirubin, 
cholesterol, lecithin, and the usual electrolytes of plasma. In the concentrating process 
in the gallbladder, water and large portions of the electrolytes (except calcium ions) 
are reabsorbed by the gallbladder mucosa; essentially all other constituents, especially 
the bile salts and the lipid substances cholesterol” and lecithin, do not get reabsorbed 
and, therefore; become highly concentrated in the GB bile. 
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 ENTEROHEPATIC CIRCULATION: 
                                     About 94% of “the bile salts are reabsorbed into the blood 
from the small intestine, about one half of this by diffusion through the mucosa in the 
early portions of the small intestine and the remainder by an active transport process 
through the intestinal mucosa in the distal ileum. They then enter the portal blood and 
pass back to the liver. On reaching the liver, on first passage through the venous 
sinusoids these salts are absorbed almost entirely back into the hepatic cells and then 
are resecreted into the bile. In this way, about 94 per cent of all the bile salts are 
recirculated into the bile, so that on the average these salts make the entire circuit 
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some 17 times before being carried out in the feces. The small quantities of bile salts 
lost into the feces are replaced by new amounts formed continually by the liver cells. 
This recirculation of the bile salts is called the enterohepatic circulation of bile salts. 
 
                                   The quantity of bile secreted by the liver each day is highly 
dependent on the availability of bile salts—the greater the quantity of bile salts in the 
enterohepatic circulation (usually a total of only about 2.5 grams), the greater the rate 
of bile secretion. Indeed, ingestion of supplemental bile salts can increase bile 
secretion by several hundred milliliters per day. If a bile fistula empties the bile salts 
to the exterior for several days to several weeks so that they cannot be reabsorbed 
from the ileum, the liver increases its production of bile salts 6- to 10-fold, which 
increases the rate of bile secretion most of the way back to normal. This demonstrates 
that the daily rate of liver bile salt secretion is actively controlled by the availability 
(or lack of availability) of bile salts in the” enterohepatic circulation. 
 
2.3 GALLSTONES- PATHOPHISIOLOGY: 
                                      The major organic contents in bile are cholesterol; bilirubin; 
bile salts and phospholipids. Gallstones “are classified as cholesterol and pigment 
stones based on their cholesterol content. In general the incidence of cholesterol 
ctones is higher than pigment” stones in Asia. 
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Cholesterol Stones: 
                    Pure cholesterol stones “are uncommon and account for <10% of all 
stones. They usually occur as single large stones with smooth surfaces. Most other 
cholesterol stones contain variable amounts of bile pigments and calcium, but are 
always >70% cholesterol by weight. These stones are usually multiple, of variable 
size, and may be hard and faceted or irregular, mulberry-shaped, and soft. Colors 
range from whitish yellow and green to black. Most cholesterol stones are radiolucent; 
<10% are radiopaque. Whether pure or of mixed nature, the common primary event in 
the formation of cholesterol stones is supersaturation of bile with cholesterol. 
Therefore, high bile cholesterol levels and cholesterol gallstones are considered as one 
disease. Cholesterol is highly nonpolar and insoluble in water and bile. Cholesterol 
solubility depends on the relative concentration of cholesterol, bile salts, and lecithin 
(the main phospholipid in bile). Supersaturation almost always is caused by 
cholesterol hypersecretion rather than by a reduced secretion of phospholipid or bile 
salts. Cholesterol is secreted into bile as cholesterol-phospholipid vesicles. Cholesterol 
is held in solution by micelles, a conjugated bile salt-phospholipid-cholesterol 
complex, as well as by the cholesterol-phospholipid vesicles. The presence of vesicles 
and micelles in the same aqueous compartment allows the movement of lipids 
between the two. Vesicular maturation occurs when vesicular lipids are incorporated 
into micelles. Vesicular phospholipids are incorporated into micelles more readily 
than vesicular cholesterol. Therefore, vesicles may become enriched in cholesterol, 
become unstable, and then nucleate cholesterol crystals.” In unsaturated bile, 
cholesterol enrichment of vesicles is inconsequential. In the supersaturated bile, 
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cholesteroldense “zones develop on the surface of the cholesterol-enriched vesicles, 
leading to the appearance of cholesterol crystals. About one third of biliary cholesterol 
is transported in micelles, but the cholesterol-phospholipid vesicles” carry the 
majority of biliary cholesterol. 
Pigment Stones:  
                                 Pigment stones contain <20% cholesterol and “are dark 
because of the presence of calcium bilirubinate. Otherwise, black and brown pigment 
stones have little in common and should be considered as separate entities. Black 
pigment stones are usually small, brittle, black, and sometimes spiculated. They are 
formed by supersaturation of calcium bilirubinate, carbonate, and phosphate, most 
often secondary to hemolytic disorders such as hereditary spherocytosis and sickle cell 
disease, and in those with cirrhosis. Like cholesterol stones, they almost always form 
in the gallbladder. Unconjugated bilirubin is much less soluble than conjugated 
bilirubin in bile. Deconjugation of bilirubin occurs normally in bile at a slow rate. 
Excessive levels of conjugated bilirubin, as in hemolytic states, lead to an increased 
rate of production of unconjugated bilirubin. Cirrhosis may lead to increased secretion 
of unconjugated bilirubin. When altered conditions lead to increased levels of 
deconjugated bilirubin in bile, precipitation with calcium occurs. 
 
                                     In Asian countries such as Japan, black stones account for a 
much higher percentage of gallstones than in the Western hemisphere. Brown stones 
are usually <1 cm in diameter, brownish yellow, soft, and often mushy. They may 
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form either in the gallbladder or in the bile ducts, usually secondary to bacterial 
infection caused by bile stasis. Precipitated calcium bilirubinate and bacterial cell 
bodies compose the major part of the stone. Bacteria such as Escherichia coli secrete 
β-glucuronidase that enzymatically cleaves bilirubin glucuronide to produce the 
insoluble unconjugated bilirubin. It precipitates with calcium, and along with dead 
bacterial cell bodies, forms soft brown stones in the biliary tree. Brown stones are 
typically found in the biliary tree of Asian populations and are associated with stasis 
secondary to parasite infection. In Western populations, brown stones occur as 
primary bile duct stones in patients with biliary strictures or” other common bile duct 
stones that cause stasis and bacterial contamination. 
  Fig 5: Mechanism of bile stone formation 
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                                       Fig 6: Cholesterol and pigment stones 
 
Choledocholithiasis:  
                         Common “bile duct stones may be small or large and single or 
multiple, and are found in 6% to 12% of patients with stones in the gallbladder. The 
incidence increases with age. About 20% to 25% of patients above the age of 60 with 
symptomatic gallstones have stones in the common bile duct as well as in the 
gallbladder. The vast majority of ductal stones in Western countries are formed within 
the gallbladder and migrate down the cystic duct to the common bile duct. These are 
classified as secondary common bile duct stones, in contrast to the primary stones that 
form in the bile ducts. The secondary stones are usually cholesterol stones, whereas 
the primary stones are usually of the brown pigment type. The primary stones are 
associated with biliary stasis and infection and are more commonly seen in Asian 
populations. 
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                                 The causes of biliary stasis that lead to the development of 
primary stones include biliary stricture,” papillary stenosis, tumors, or other 
(secondary) stones. 
Acute Cholecystitis:  
                                     Gall stones are the “initiating event in 90-95% of the cases. 
Tumour contributes to only 1% of the cases. Acalculous cholecytitis is found to occur 
as a part of systemic disease. Cystic duct gets obstructed by the gall stone, following 
which the gall bladder gets distended and the inflammatory process begin. Toxin 
lysolecithin, a product of lecithin, is released along with bile salts and platelet 
aggregating  factor, these are the mediators invloved in the inflammatory process. This 
process gets amplified by increase in prostaglandin synthesis. Secondary bacterial 
infection occurs in 15% to 30% of patients. In acute cholecystitis, GB wall becomes 
thickened and subserosal haemorrhages are seen. The mucosa is hyperaemic and 
patchy necrosis of the mucosa occurs. The gall stone dislodges and the inflammatory 
process subsides in” most of the cases, but in few cases the inflammation will progress 
leading to the necrosis of the entire gall bladder wall. 
 
Chronic Cholecystitis:  
                                    About two thirds of patients “with gallstone disease present 
with chronic cholecystitis characterized by recurrent attacks of pain, often 
inaccurately labeled biliary colic. The pain develops when a stone obstructs the cystic 
duct, resulting in a progressive increase of tension in the gallbladder wall. The 
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pathologic changes, which often do not correlate well with symptoms, vary from an 
apparently normal gallbladder with minor chronic inflammation in the mucosa, to a 
shrunken, nonfunctioning gallbladder with gross transmural fibrosis and adhesions to 
nearby structures. The mucosa is initially normal or hypertrophied, but later becomes 
atrophied, with the epithelium protruding into the muscle coat, leading to the 
formation of the” so-called Aschoff- Rokitansky sinuses. 
 
2.4 Clinical Features 
                                      Gallstone disease is one of the most “common problems 
affecting the digestive tract. Autopsy reports have shown a prevalence of gallstones 
from 11% to 36%. The prevalence of gallstones is related to many factors, including 
age, gender, and ethnic background. Certain conditions predispose to the development 
of gallstones. Obesity, pregnancy, dietary factors, Crohn’s disease, terminal ileal 
resection, gastric surgery, hereditary spherocytosis, sickle cell disease, and 
thalassemia are all associated with an increased risk of developing gallstones. Women 
are three times more likely to develop gallstones than men, and first-degree relatives 
of patients with gallstones have a” twofold greater prevalence. 
 
Natural History 
                                  Most patients will remain “asymptomatic from their gallstones 
throughout life. For unknown reasons, some patients progress to a symptomatic stage, 
with biliary colic caused by a stone obstructing the cystic duct. Symptomatic gallstone 
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disease may progress to complications related to the gallstones. These include acute 
cholecystitis, choledocholithiasis with or without cholangitis, gallstone pancreatitis, 
cholecystocholedochal fistula, cholecystoduodenal or cholecystoenteric fistula leading 
to gallstone ileus, and gallbladder carcinoma. 
 
                                    Rarely, complication of gallstones is the presenting picture. 
Gallstones in patients without biliary symptoms are commonly diagnosed incidentally 
on ultrasonography, CT scans, or abdominal radiography or at laparotomy. Several 
studies have examined the likelihood of developing biliary colic or developing 
significant complications of gallstone disease. Approximately 3% of asymptomatic 
individuals become symptomatic per year (i.e., develop biliary colic). Once 
symptomatic, patients tend to have recurring bouts of biliary colic. Complicated 
gallstone disease develops in 3% to 5% of symptomatic patients per year. Over a 20-
year period, about two thirds of asymptomatic patients with gallstones remain 
symptom free. Because few patients develop complications without previous biliary 
symptoms, prophylactic cholecystectomy in asymptomatic persons with gallstones is 
rarely indicated. For elderly patients with diabetes, for individuals who will be 
isolated from medical care for extended periods of time, and in populations with 
increased risk of gallbladder cancer, a prophylactic cholecystectomy may be 
advisable. Porcelain gallbladder, a rare premalignant condition in which the wall of 
the gallbladder becomes calcified,” is an absolute indication for cholecystectomy. 
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Acute Cholecystitis: 
                                    About 80% of patients with acute cholecystitis give a history 
compatible with chronic “cholecystitis. Acute cholecystitis begins as an attack of 
biliary colic, but in contrast to biliary colic, the pain does not subside; it is unremitting 
and may persist for several days. The pain is typically in the right upper quadrant or 
epigastrium and may radiate to the right upper part of the back or the interscapular 
area. It is usually more severe than the pain associated with uncomplicated biliary 
colic. The patient is often febrile, complains of anorexia, nausea,” and vomiting, and 
is reluctant to move, as the inflammatory process affects the parietal peritoneum. 
 
                                   On physical examination, focal tenderness and guarding are 
usually present in the right “upper quadrant. A mass, the gallbladder and adherent 
omentum, is occasionally palpable; however, guarding may prevent this. A Murphy’s 
sign, an inspiratory arrest with deep palpation in the right subcostal area, is 
characteristic of acute cholecystitis. A mild to moderate leukocytosis (12,000–15,000 
cells/mm3) is usually present. However, some patients may have a normal WBC. A 
high WBC count (above 20,000) is suggestive of a complicated form of cholecystitis 
such as gangrenous cholecystitis, perforation, or associated cholangitis. Serum liver 
chemistries are usually normal, but a mild elevation of serum bilirubin, <4 mg/mL, 
may be present along with mild elevation of alkaline phosphatase, transaminases, and 
amylase. Severe jaundice is suggestive of common bile duct stones or obstruction of 
the bile ducts by severe pericholecystic inflammation secondary to impaction of a 
stone in the infundibulum of the gallbladder that mechanically obstructs the bile duct 
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(Mirizzi’s syndrome). In elderly patients and in those with diabetes mellitus, acute 
cholecystitis may have a subtle presentation resulting in a delay in diagnosis. The 
incidence of complications is higher in these patients, who also have approximately 
10-fold the mortality rate compared” to that of younger and healthier patients. 
 
                                     The differential “diagnosis for acute cholecystitis includes a 
peptic ulcer with or without perforation, pancreatitis, appendicitis, hepatitis, 
perihepatitis (Fitz-Hugh–Curtis syndrome), myocardial ischemia, pneumonia, 
pleuritis, and herpes” zoster involving the intercostal nerve. 
Chronic Cholecystitis: 
                                    The chief “symptom associated with symptomatic gallstones is 
pain. The pain is constant and increases in severity over the first half hour or so and 
typically lasts 1 to 5 hours. It is located in the epigastrium or right upper quadrant and 
frequently radiates to the right upper back or between the scapulae. The pain is severe 
and comes on abruptly, typically during the night or after a fatty meal. It often is 
associated with nausea and sometimes vomiting. The pain is episodic. The patient 
suffers discrete attacks of pain, between which they feel well. Physical examination 
may reveal mild right upper quadrant tenderness during an episode of pain. If the 
patient is pain free, the physical examination” is usually unremarkable. 
                                    Laboratory values, such as WBC count and liver function tests, 
are usually normal in patients with uncomplicated “gallstones. Atypical presentation 
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of gallstone disease is common. Association with meals is present in only about 50% 
of patients. Some patients report milder attacks of pain, but relate it to meals. The pain 
may be located primarily in the back or the left upper or lower right quadrant. 
Bloating and belching may be present and associated with the attacks of pain. In 
patients with atypical presentation, other conditions with upper abdominal pain should 
be sought out, even in the presence of gallstones. These include peptic ulcer disease, 
gastroesophageal reflux disease, abdominal wall hernias, irritable bowel disease, 
diverticular disease, liver diseases, renal calculi, pleuritic pain, and myocardial pain. 
Many patients with other conditions have gallstones. When the pain lasts >24 hours, 
an impacted stone in the cystic duct or acute cholecystitis should be suspected. An 
impacted stone without cholecystitis will result in what is called hydrops of the 
gallbladder. The bile gets absorbed, but the gallbladder epithelium continues to secrete 
mucus, and the gallbladder becomes distended with mucinous material. The 
gallbladder may be palpable but usually is not tender. Hydrops of the gallbladder may 
result in edema of the gallbladder wall, inflammation, infection, and perforation. 
Although hydrops may persist” with few consequences, early cholecystectomy is 
generally indicated to avoid complications. 
Essentials of Diagnosis: 
✓ Episodic abdominal pain. 
✓ Dyspepsia 
✓ Gallstones on cholecystography or ultrasound scan. 
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                        Commonly, the first test, ultrasonography, is useful for documenting 
“stones in the gallbladder (if still present), as well as determining the size of the 
common bile duct. As stones in the bile ducts tend to move down to the distal part of 
the common duct, bowel gas can preclude their demonstration on ultrasonography. A 
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dilated common bile duct (>8 mm in diameter) on ultrasonography in a patient with 
gallstones, jaundice, and biliary pain is highly suggestive of common bile duct stones. 
Magnetic resonance cholangiography (MRC) provides excellent anatomic detail and 
has a sensitivity and specificity of 95% and 89%, respectively, at detecting 
choledocholithiasis >5 mm in diameter. Endoscopic cholangiography is the gold 
standard for diagnosing common bile duct stones. It has the distinct advantage of 
providing a therapeutic option at the time of diagnosis. In experienced hands, 
cannulation of the ampulla of Vater and diagnostic cholangiography are achieved in 
>90% of cases, with associated morbidity of <5% (mainly cholangitis and 
pancreatitis). Endoscopic ultrasound has been demonstrated to be as good as ERCP 
for detecting common bile duct stones (sensitivity of 91% and specificity of 100%), 
but it lacks therapeutic intervention and requires expertise, making it less available. 
PTC is rarely needed in patients with secondary common bile duct stones but is 
frequently performed for both diagnostic and” therapeutic reasons in patients with 
primary bile duct stones. 
 
2.5 Diagnostic Studies 
Baseline Blood Investigations: 
     • Complete hemogram 
     • Differential Count 
     • Renal Function Test 
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     • Liver Function Test including liver enzymes 
     • Fasting Lipid Profile 
 Prothrombin time 
                              When patients with “suspected diseases of the gallbladder or the 
extrahepatic biliary tree are evaluated, a complete blood count and liver function tests 
are routinely requested. An elevated white blood cell (WBC) count may indicate or 
raise suspicion of cholecystitis. If associated with an elevation of bilirubin, alkaline 
phosphatase, and aminotransferase, cholangitis should be suspected. Cholestasis, an 
obstruction to bile flow, is characterized by an elevation of bilirubin (i.e., the 
conjugated form) and a rise in alkaline phosphatase. Serum aminotransferases may be 
normal or mildly elevated. In patients with biliary colic or chronic cholecystitis, blood 
tests will typically be normal”. A variety of diagnostic modalities; are available. 
                                     The diagnosis of gallstones was improved significantly by the 
introduction of “ oral cholecystography by Graham and Cole”. For several years, it 
remained the investigation for gallstones. In the 1950s, “biliary scintigraphy was 
developed, as well as intrahepatic and endoscopic retrograde cholangiography (ERC), 
allowing imaging of the biliary tract. Later ultrasonography, computed tomography 
(CT), and magnetic resonance imaging (MRI)” improved the ability to image the 
biliary tract. 
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Fig7: Multiple gallstones in a plain X- ray Abdomen                                                                            
showing radio-opaque shadow 
  Ultrasonography: 
                                  An ultrasound is the initial investigation of any patient suspected 
of disease of the biliary tree. It is “ non-invasive, painless, does not submit the patient 
to radiation, and can be performed on critically ill patients. It is dependent upon the 
skills and the experience of the operator, and it is dynamic (i.e., static images do not 
give the same information as those obtained during the ultrasound investigation itself). 
Adjacent organs can frequently be examined at the same time. Obese patients, patients 
with ascites, and patients with distended bowel may be difficult to examine 
satisfactorily with an ultrasound. Ultrasound will show stones in the gallbladder with 
sensitivity and specificity of >90%. Stones are acoustically dense and reflect the 
ultrasound waves back to the ultrasonic transducer. Because stones block the passage 
of sound waves to the region behind them, they also produce an acoustic shadow. 
Stones move with changes in position. Polyps may be calcified and reflect shadows, 
but do not move with change in posture. Some stones form a layer in the gallbladder; 
others a sediment or sludge. A thickened gallbladder wall and local tenderness 
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indicate cholecystitis. The patient has acute cholecystitis if a layer of edema is seen 
within the wall of the gallbladder or between the gallbladder and the liver in 
association with localized tenderness.” When a stone obstructs the neck of the 
gallbladder, the gallbladder may become very large, but thin walled. A contracted, 
thick-walled gallbladder is indicative of chronic cholecystitis. 
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 Fig 8: Ultrasound: gallbladder showing echogenic lesion. US should be done with change of 
position to find out movement of the lesion with posterior acoustic shadow to say it as 
gallstone. Otherwise it will be gallbladder polyp or sludge ball. 
 
 
 
 
Oral Cholecystography: 
                                          Once considered the diagnostic procedure of choice for 
gallstones, “oral cholecystography has largely been replaced by ultrasonography. It 
involves oral administration of a radiopaque compound that is absorbed, excreted by 
the liver, and passed into the gallbladder. Stones are noted on a film as filling defects 
in a visualized, opacified gallbladder. Oral cholecystography is of no value in patients 
with intestinal malabsorption, vomiting, obstructive” jaundice, and hepatic failure. 
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Fig 9: Oral cholecystogram with smooth filling defect (Cystic duct stone). 
 
Biliary Radionuclide Scanning (HIDA Scan) 
                                    Biliary scintigraphy; provides a noninvasive evaluation of the 
liver, GB, ducts, and duodenum ; with anatomic and functional information. 
“99mTechnetium-labeled derivatives of dimethyl iminodiacetic acid (HIDA) are 
injected intravenously, cleared by the Kupffer cells in the liver, and excreted in the 
bile. Uptake by the liver is detected within 10 minutes, and the gallbladder, the bile 
ducts, and the duodenum are visualized within 60 minutes in fasting subjects. The 
primary use of biliary scintigraphy is in the diagnosis of acute cholecystitis, which 
appears as a nonvisualized gallbladder, with prompt filling of the common bile duct 
and duodenum. Evidence of cystic duct obstruction on biliary scintigraphy is highly 
diagnostic for acute cholecystitis. The sensitivity and specificity for the diagnosis are 
about 95% each. False-positive results are increased in patients with gallbladder stasis, 
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as in critically ill patients and in patients receiving parenteral nutrition. Filling of the 
gallbladder and common bile duct with delayed or absent filling of the duodenum 
indicates an obstruction at the ampulla. Biliary leaks as a complication of surgery of 
the gallbladder or the biliary” tree can be confirmed and frequently localized by 
biliary scintigraphy. 
 
 Percutaneous Transhepatic Cholangiography: 
                                       Intrahepatic bile ducts are accessed percutaneously “with a 
small needle under fluoroscopic guidance. Once the position in a bile duct has been 
confirmed, a guidewire is passed, and subsequently, a catheter is passed over the wire 
through the catheter, a cholangiogram can be performed and therapeutic interventions 
done, such as biliary drain insertions and stent placements. Percutaneous transhepatic  
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cholangiography (PTC) has little role in the management of patients with 
uncomplicated gallstone disease but is particularly useful in patients with bile duct 
strictures and tumors, as it defines the anatomy of the biliary tree proximal to the 
affected segment. As with any invasive procedure, there are potential risks. For PTC, 
these are mainly bleeding, cholangitis, bile leak”, and other catheter-related problems 
.
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 Fig 10: MRCP- This view shows 
the course of the extra- hepatic biliary tree marked by the arrow heads. 
  
Fig 11A: Endoscopic retrograde cholangiography. A schematic picture showing the side-
viewing endoscope in the duodenum. 
           B:   An endoscopic cholangiography image showing Pancreatic duct, CBD, ampulla. 
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Endoscopic Ultrasound 
                                    Endoscopic ultrasound “requires a special endoscope with an 
ultrasound transducer at its tip. The results are operator dependent, but offer 
noninvasive imaging of the bile ducts and adjacent structures. It is of particular value 
in the evaluation of tumors and their resectability. The ultrasound endoscope has a 
biopsy channel, allowing needle biopsies of a tumor under ultrasonic guidance. 
Endoscopic ultrasound also has been used to identify bile duct stones, and although it 
is less sensitive than ERC, the technique is less invasive as cannulation of the 
sphincter of Oddi is not necessary” for diagnosis of choledocholithiasis. 
2.6 Management 
Symptomatic Gallstones 
                                     Patients with symptomatic gallstones should be advised to 
have “elective laparoscopic cholecystectomy.” While waiting for surgery; or if 
surgery has to be postpone; the patient should be advised to avoid dietary fats and 
large meals. Diabetic patients with symptomatic gallstones; should have a 
cholecystectomy promptly; as they are more prone to develop acute severe 
cholecystitis . 
 
                                      Pregnant women with symptomatic gallstones; who cannot be 
managed expectantly with diet modifications can safely undergo laparoscopic 
cholecystectomy; during the 2nd trimester. “Laparoscopic cholecystectomy is safe and 
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effective in children as well as in the elderly. Cholecystectomy, open or laparoscopic, 
for patients with symptomatic gallstones offers excellent long-term results.” About 
90% of patients with “typical biliary symptoms and stones are rendered symptom free 
after cholecystectomy. For patients with atypical symptoms or dyspepsia (flatulence, 
belching, bloating, and dietary fat intolerance) the results are not” as favorable. 
 
Acute Cholecystitis 
                                     Patients who present with acute cholecystitis will need IV 
fluids, antibiotics, and analgesia. “The antibiotics should cover gram-negative aerobes 
as well as anaerobes. A third generation cephalosporin with good anaerobic coverage 
or a second-generation; cephalosporin combined with metronidazole is a typical 
regimen. Cholecystectomy is the definitive treatment for acute cholecystitis. In the 
past, the timing of cholecystectomy has been a matter of debate. Early 
cholecystectomy performed within 2 to 3 days of the illness is preferred over interval 
or delayed cholecystectomy that is performed 6 to 10 weeks after initial medical 
treatment and recuperation. Several studies have shown that unless the patient is unfit 
for surgery, early cholecystectomy should be recommended, as it offers the patient a 
definitive solution in one hospital admission, quicker recovery times, and an earlier 
return to work. Laparoscopic cholecystectomy is the procedure of choice for acute 
cholecystitis. The conversion rate to an open cholecystectomy is higher (10%– 15%) 
in the setting of acute cholecystitis than with chronic cholecystitis. When patients 
present late, after 3 to 4 days of illness, or if they are unfit for surgery, they can be 
treated with antibiotics with laparoscopic cholecystectomy scheduled for 
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approximately 2 months later. Approximately 20% of patients will fail to respond to 
initial medical therapy and require an intervention. For those unfit for surgery, a 
percutaneous cholecystostomy or an open cholecystostomy under local analgesia can 
be performed. Failure to improve after cholecystostomy usually is due to gangrene of 
the gallbladder or perforation. For these patients, surgery is unavoidable. For those 
who respond after cholecystostomy, the tube can be removed once cholangiography 
through it shows a patent ductus cysticus. Laparoscopic cholecystectomy may then be 
scheduled in the near future. For the rare patients who can’t tolerate surgery, the 
stones can be extracted” via the cholecystostomy tube before its removal. 
 
Choledocholithiasis 
                                     For patients with; symptomatic gallstones and suspected 
common bile duct stones; either preoperative “endoscopic cholangiography or an 
intraoperative cholangiogram will document the bile duct stones. If an endoscopic 
cholangiogram reveals stones, sphincterotomy and ductal clearance of the stones is 
appropriate, followed by a laparoscopic cholecystectomy. An intraoperative 
cholangiogram at the time of cholecystectomy will also document the presence or 
absence of bile duct stones. Laparoscopic common bile duct exploration via the cystic 
duct or with formal choledochotomy allows the stones to be retrieved in the same 
setting. An open common bile duct exploration is an option if the endoscopic method 
has already been tried or is, for some reason, not feasible. If a choledochotomy is 
performed, a T tube is left in place. Patients >70 years old presenting with bile duct 
stones should have their ductal stones cleared endoscopically. Studies comparing 
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surgery to endoscopic treatment have documented less morbidity and mortality for 
endoscopic treatment in this group of patients. They do not need to be submitted for a 
cholecystectomy, as only about 15% will become symptomatic from their gallbladder 
stones, and such patients can be treated as the need arises” by a cholecystectomy. 
 
Surgical Interventions in Biliary Disease: 
Cholecystostomy: 
                                  This procedure is performed in patients who are unfit for 
anaesthesia. In this procedure under ultrasound guidance the distended gall bladder is 
decompressed by percutaneous drainage. Initially a guide- wire is inserted through the 
abdominal wall, liver and the gall bladder, then a catheter is passed over it. Once the 
patient’s condition has improved the catheter is removed and cholecystectomy can be 
done at a later date. This procedure is rarely performed nowadays. 
 
Laparoscopic Cholecystectomy: 
                                       Philippe Mouret from France was the one who introduced 
Lap Cholecystectomy in the year 1987 which has revolutionised the treatment of 
gallstones. Most of laparoscopic cholecysyectomies are done for the purpose of biliary 
colic, but it can also be safely caried out in acute settings, except that the conversion 
rates to open are higher. It is perfomed under general anaesthesia. Because of the 
smaller incisions, less pain and shorter hospital stay increasing number of 
laparoscopic cholecystectomies are being performed. 
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Open Cholecystectomy:  
                                  Due to the advent of laparoscopic technique the number of 
open procedures has drastically come down. It is now performed under two settings, 
one following conversion of the laparoscopic approach and two as a step during 
another surgery like pancreaticoduodenectomy.  
 
Common Bile Duct Exploration:  
                             Laparoscopic techniques have been improvised in the recent years 
which have paved the way for laparoscopic clearance of the bile duct is being 
practised. First the CBD is visualised fluroscopically, the duct is irrigated. Glucagon is 
instilled which relaxes the sphincter of Oddi. If the attempt fails a flexible 
choledochoscope is used. In both open and laparoscopic methods, stay sutures are 
made, and a choledochotomy is performed in the supraduodenal portion of the CBD. 
Usually a longitudinal incision is made and the stone is retrieved. At the end of the 
procedure a T- tube is placed via the choledochotomy site and the duct is closed with 
absorbable sutures. 
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Fig 12: Lap and open techniques 
 
 
 
2.7 Thyroid Function 
Hypothyroidism: 
                          Hypothyroidism is a common disorder; again especially in women, 
the incidence being about 350/100 000 women yearly. The prevalence of subclinical 
hypothyroidism among women over 60 years of age is as high as 20%. 
Hypothyroidism; is defined as “ in any state which results in a deficiency of TH, 
including hypothalamic or pituitary diseases, generalized tissue resistance to TH, and 
disorders directly affecting the thyroid gland. Thyroid deficiency in adults is 
characterized by a slowing of all metabolic processes.” The  clinical symptoms of the 
condition include “weakness, lethargy and fatigue, memory impairment, dementia, 
cold intolerance, weight gain, constipation, loss of hair, hoarseness, deafness, 
dyspnea, myalgia and arthralgia, paraesthesias, precordial pain and menstrual 
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irregularity. When THs are lacking in early childhood, the result is severe bodily and 
mental retardation. Clinical signs of hypothyroidism may be dry, coarse and cold skin, 
periorbital and peripheral oedema, coarse and thin hair, pallor of skin, thick tongue, 
slow speech, decreased reflexes, hypertension, bradycardia, pleural and pericardial 
effusions, ascites and vitiligo. In laboratory tests, e.g. hypercholesterolaemia and 
anaemia are associated findings.” The laboratory hallmark of primary hypothyroidism 
and the most sensitive test for detecting early thyroid failure is an “increased serum 
TSH concentration. The serum FT4 level is decreased in clinical hypothyroidism. In 
the subclinical form an increased serum TSH level is accompanied by a normal serum 
FT4 level, and the patient is asymptomatic.” The presence of thyroperoxidase 
antibody confirms chronic autoimmune thyroiditis as the cause of hypothyroidism. 
The treatment of hypothyroidism with levothyroxine is usually lifelong. 
 
The effects of thyroid hormones: 
                                           The thyroid gland secretes both T4 and triiodothyronine 
(T3) into the circulation. “In extrathyroidal tissues, T4 is converted to T3, assumed to 
be the major active TH. Characteristic of THs is the multiplicity of the cellular 
functions they regulate in virtually every type of vertebrate tissue. The diverse 
responses to TH can be divided into two major categories: 
 Regulation of metabolic activity, energy consumption and muscular activity in 
adult mammals, and 
 Regulation of postembryonic or perinatal growth and development.  
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Most actions of THs can be explained by their interaction with nuclear receptors. THs 
bind to specific intranuclear TH receptors (TR), TR1, TR1 or TR2. This ligand-
receptor complex binds to TH response elements in the target genes to regulate the 
rate of synthesis of specific messenger RNAs. This results in a change in the amount 
or activity of the cognate proteins, which in turn alter the rate of the metabolic 
process. The TRs are expressed in a tissue- and development-stage-specific fashion. 
For example, TR1 is known to be highly expressed in brain, muscle and fat, and has 
been identified in frog, chicken, rat, mouse and humans; TR1 is highly expressed in 
liver and kidney, and has been demonstrated in frog, chicken, rat, mouse and humans. 
TR2, again, is highly expressed in the pituitary, and has been demonstrated in rat and 
mouse. The expression of TRs in the SO has not been studied. The genomic effects of 
THs necessarily require a finite period of time for protein synthesis and for the 
biological response. Acute response of a cell to THs is unlikely to involve a 
transcriptional mechanism but is rather a result of nongenomic mechanisms involving 
extranuclear sites of action. Extranuclear sites of TH action include the cell 
membrane, the cytoskeleton, the sarcoplasmic reticulum, the cytoplasm, the 
mitochondria, and in vascular smooth-muscle cells presumably the contractile 
elements.” For example, THs mediate sugar uptake, adenylate cyclase, and Ca2+- 
ATPase activity directly at the level of the plasma membrane of various tissues. The 
second messengers associated with the extranuclear actions of the THs are not yet 
known. 
 
Thyroid hormones and cholesterol metabolism: 
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                                         THs have been shown to have a number of effects on 
cholesterol metabolism. LDL “receptor activity is increased (Ness et al. 1990) because 
of increased expression of the LDL receptor gene, and the expression may be 
decreased in hypothyroidism, leading to reduced removal of cholesterol from the 
serum. THs increase the synthesis of cholesterol by regulating the expression of 
HMG-CoA reductase, and the regulation is reduced in hypothyroid patients, leading to 
decreased cholesterol synthesis. Also the synthesis of bile salts is increased by THs by 
the effect on cholesterol-7-hydroxylase, and a decrease in biliary bile salt 
concentration in hypothyroidism has been reported. Absorbtion of cholesterol is 
decreased by THs. Hypothyroidism lowers biliary cholesterol secretion in the rat, 
while T4 replacement in hypothyroid animals markedly increases cholesterol 
secretion. However, in the cholesterol-fed hypothyroid rat, biliary cholesterol content 
62 
 
is significantly increased and the rate of bile secretion decreased. Biliary secretion of 
cholesterol is reduced in hypothyroidism compared to euthyroidism. However, when 
serum cholesterol values rise, bile may also become supersaturated with cholesterol 
and thus result in gallstone formation. An association has been reported between 
cholesterol gallstones and treated hypothyroidism in women.” It has also been 
reported that gallbladder stones may have been dissolved after T4 treatment. 
 
2.8 Prevalence of Clinical Hypothyroidism in Gall Stone Patients 
                                      Several recent studies report an association between 
hypothyroidism, and subclinical hypothyroidism, and gall stones. In a retrospective 
study on patients over 60 years of age, it was noted for the first time that CBD stone 
“p"atients have significantly more diagnosed hypothyroidism (11%), not only when 
compared to “control patients from whom gallstones had been excluded (2%), but also 
when compared to gallbladder stone patients without CBD stones (6%). In this study, 
there was no difference between groups in the frequency of other diseases. This 
finding suggested that factors other than merely those affecting cholesterol 
metabolism, for example, specific effects on bile flow, might be behind the 
association between CBD stones and hypothyroidism. A prospective study showed 
that even subclinical hypothyroidism is more common among gall stone patients. This 
study investigated the prevalence of previously undiagnosed subclinical 
hypothyroidism in clinically euthyroid CBD stone patients compared to nongallstone 
controls. It was found that 5.3% of the gall stone patients had subclinical 
hypothyroidism, defined as serum thyrotropin above the normal upper limit (6.0 
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mU/L), compared to only 1.4% in the control group. In women over 60 years, the 
prevalence of subclinical hypothyroidism was as high as 11.4% in the gall stone 
group” compared to 1.8% among” the control patients. 
 
                                  Finally in 2010, “a large, medical registry-based study from 
Finland confirmed that hypothyroid patients did indeed seem to have a higher 
likelihood for gall stone treatment. In this study, the prevalence of gall stone 
treatments was investigated in patients with diagnosed hypothyroidism and compared 
to age, sex, and area of residence adjusted glaucoma (control) patients. Patients with 
other diseases were excluded to create a “purely” hypothyroid (or glaucoma) cohort of 
patients. Out of 14,334 patients in each group who met the inclusion criteria, 0.23% in 
the hypothyroid cohort and 0.16% in the control cohort had been treated for gall 
stones. The groups did not differ in the number of gall stone treatments before the 
diagnosis of hypothyroidism or glaucoma, but after these diagnoses there were 56% 
more gall stone treated individuals in the hypothyroid cohort than in the control 
cohort. This may suggest that the higher risk for gall stones in hypothyroid patients 
may increase after taking medication for hypothyroidism. As the process of bile stone 
formation takes time, stone formation may have started during the untreated period of 
hypothyroidism and have been completed regardless of thyroxine replacement 
therapy. This hypothesis is supported by the findings that both subclinical and clinical 
hypothyroidism are more common in gall stone patients. However, the question 
remains whether thyroxine replacement therapy is sufficient to cause the physiological 
effects of thyroxine, as it seems that even though thyroxine replacement therapy has 
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been initiated, the gall stones do indeed form or continue to grow. Earlier studies with 
subclinical hypothyroid patients have demonstrated that a positive effect on changes 
in the cholesterol level, cardiovascular effects, or neuromuscular symptoms may be 
achieved with early replacement treatment with thyroxine. It has also been reported 
that gallstones have dissolved after initiation of thyroxine therapy. It is possible that 
thyroxine replacement therapy is  not sufficient at all times of the day, in all patients 
to maintain normal sphincter of Oddi function, causing the formation of gall stones. 
These interesting findings raise a question” about the mechanisms underlying the 
association, which is stronger between hypothyroidism and CBD stones than between 
hypothyroidism and gallbladder stones. 
 
Mechanism of Formation of Gallstones in Hypothyroidism:                                                                                     
In general, the pathogenesis of gallstones is a complex process involving mechanisms 
affecting bile content and bile flow. There are several factors that may contribute to 
the formation of gall stones in hypothyroid patients. Based on the investigations 
currently available, it cannot be concluded whether hypothyroid individuals develop 
isolated gall stones or present with CBD stones in addition to gallbladder stones. 
“However, based on what is known about the effects of hypothyroidism on the 
formation of gallbladder and CBD stones, it seems likely that in hypothyroidism both 
the risk for gallbladder-originated as well as for de novo CBD stones is increased.” 
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In hypothyroidism, the lack of thyroxine 
➢ decreases liver cholesterol metabolism resulting in bile cholesterol supersaturation, 
which in turn impairs the motility, contractility, and filling of the gallbladder, 
contributing to the retention of cholesterol crystals and to the nucleation and growth of 
gallstones. 
➢ diminishes bile secretion from hepatocytes resulting in impaired clearance of 
precipitates from the bile ducts. 
➢reduces SO relaxation resulting in delayed bile flow and thus the formation and    
accumulation of CBD stones. 
                                     THs regulate multiple functions in virtually every type of 
vertebrate tissue. Most actions of THs can be explained by their interaction with 
nuclear receptors, which are expressed in a tissue- and development stage-specific 
fashion. In human, the SO expresses both TR β1 and β2. Any acute-type response of a 
cell to THs is unlikely to involve a transcriptional mechanism but is rather a result of 
nongenomic mechanisms involving extranuclear sites of action. In general, thyroid 
hormone actions are largely intracellular events that require transport across the 
plasma membrane. Recently, several active and specific thyroid hormone transporters 
have been identified, including monocarboxylate transporter 8 (MCT8), MCT10, and 
organic anion transporting polypeptide 1C1 (OATP1C1).  
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Hypothyroidism Reduces Bile Flow into the Duodenum: 
                                         In a “rat study where the effect of SO was not excluded by 
cannulation, hypothyroidism reduced and hyperthyroidism increased the bile flow into 
the duodenum. Similarly, in a prospective human study, hepatic clearance was 
significantly decreased and the hilum-duodenum transit time had a tendency to 
increase in the hypothyroid stage after thyroidectomy, when compared to the 
euthyroid stage in the same patients. As the hepatic maximal uptake and the 
appearance of radioactivity in the large bile ducts at the hepatic hilum were similar in 
the hypothyroid and euthyreotic stages of this study, the findings are hardly 
attributable to different hepatic secretion but strongly suggest that bile flow into the 
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duodenum is reduced in the hypothyroid stage. This could be due to changes in bile 
composition and gallbladder motility, and because of changes” in the resistance to 
flow, that is, in the SO motility. 
 
Hypothyroidism Leads to Impaired SO Relaxation: 
                                                    The existence “of gastrointestinal hypoactivity in 
hypothyroidism has been well known for decades. For example, the effect of 
thyroxine has been documented in anal canal pressure and in lower esophageal 
sphincter pressure. The effect of THs on smooth muscle contraction depends on the 
smooth muscle type and the species studied. THs have a direct, relaxing effect on 
vascular smooth muscle contractility. This effect is mediated by intranuclear binding 
of TH to the TR, and partly by nongenomic mechanisms involving extranuclear sites 
of action. The potassium (K+) channel blocker glibenclamide attenuates 
triiodothyronine-induced vasodilatation in rat skeletal muscle arteries, and 
triiodothyronine-induced vasodilatation may thus be mediated by ATP-sensitive K+- 
channels. Since Sandblom et al. first demonstrated the hormonal action of 
cholecystokinin (CCK) on the SO in 1935; several other hormones have been shown 
to affect SO activity. In 2001, it was shown for the first time that thyroxine has a 
direct effect on SO contractility in physiological concentrations in pig experiments.” 
Triiodothyronine had a similar effect on thyroxine, whereas cortisone, estrogen and 
testosterone had no effect. Thus the effect of THs is not an unspecific effect of any 
hormone. Progesterone, which is thought to be involved in the smooth muscle 
68 
 
relaxation seen in pregnancy, reduced not only the ACh- and Hist-induced but also 
 
 
Mechanisms by Which Thyroxine Mediates SO Relaxation: 
                              Several “examinations were performed to determine how the 
relaxant effect of thyroxine on SO is mediated. The experiments with α- and β-
adrenoceptor antagonists, NO synthesis inhibitor, and the elimination of nerve 
function with tetrodotoxin showed that the thyroxine-induced relaxation of SO is not 
mediated via neural effects. Human SO was shown to express TR β1 and β2. The 
presence of TRs in the SO is necessary but not sufficient evidence that thyroxine 
exerts its prorelaxant effect via a hormone-receptor complex action. However, the 
experiments with different incubation times of thyroxine showed that the underlying 
cellular mechanisms involved do not act immediately but require a certain time lag, 
supporting the theory that at least part of the action of thyroxine is TH-TR mediated. 
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The passage of TH through cell membrane, cytoplasm, and nuclear membrane and 
binding to a nuclear protein (TR) is a relatively fast event, whereas the resulting 
transcriptional and translational regulation is time consuming, and probably explains 
why the relaxant effect is not immediate. Thus, the effect of thyroxine could be 
mediated by regulatory proteins partly synthesized as a result of thyroxine-induced 
gene expression. The prorelaxant effect of thyroxine is probably partly mediated via 
transporter proteins, and partly via binding to nuclear receptors, subsequently leading 
to the activation of K+ channels.” The opening of K+ channels is followed by 
hyperpolarisation, which closes cell membrane Ca2+ channels, reduces Ca2+ influx, 
and results in reduced contraction of the SO smooth-muscle cell in response to any 
specific stimulus. 
 
Conclusions and Clinical Implications: 
                                     In summary, several recent studies “report an association 
between hypothyroidism, or subclinical hypothyroidism, and gall stones. The higher 
prevalence of hypothyroidism in gall stone patients compared to gallbladder stone 
patients suggests that not only changes in the cholesterol metabolism, or bile excretion 
rate, but particularly changes in the function of the SO that may underline the 
association between gall stones and hypothyroidism. It remains to be investigated 
whether hypothyroid individuals who have had their gallbladder removed are at an 
increased risk to develop CBD stones when compared to euthyroid individuals in the 
same situation. It seems likely that the lack of thyroxine in hypothyroidism gives rise 
to a reduction in bile flow in many ways. In addition to the increased cholesterol load 
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in bile and the reduced bile secretion rate, the deficiency of the pro relaxant effect of 
thyroxine on the SO appears to be a crucial factor leading to the reduced bile flow in 
hypothyroidism. The initial formation of bile cholesterol crystals may begin during the 
untreated period of hypothyroidism, and the stones may continue to develop or mature 
even after the thyroxine replacement therapy has begun. It is possible that thyroxine 
replacement therapy is not sufficient in all patients to maintain normal SO function, 
causing increased risk of CBD stone formation. Studies with subclinical hypothyroid 
patients have demonstrated that a positive effect on the changes in the serum 
cholesterol level, on cardiovascular effects, or on neuromuscular symptoms may be 
achieved with early replacement treatment with thyroxine, and it can be assumed that 
patients at risk of forming gall stones due to subclinical hypothyroidism may also 
benefit from such early treatment. In conclusion patients presenting with gallstones, 
especially females clinicians should be aware of the hypothyroid backround and 
perform a thyroid profile.” 
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                           MATERIALS AND METHODS 
3.1 Type of study: Prospective and observational study 
3.2 Approval        :  Prior to conducting the study approval was  
                                  obtained from the ethical committee of Thanjavur 
                                  Medical College, Thanjavur. 
3.3 Study Place:  Thanjavur Medical College & Hospital, 
     Thanjavur – 613004. 
3.4 Study Period :  2014 June to 2015 August 
3.5 Sample size:  
3.6 Inclusion Criteria: 
             1. Patients in age group of 18-70 yrs and 
            2. Patients with USG proven cholelithiasis/ choledocholithiasis 
3.7 Investigation 
             1. USG abdomen 
             2. T3, T4, TSH 
3.7 Study procedure: 
                                  Method of sampling was non-random, purposive. After 
admission short historywas taken and physical examination was conducted on each 
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patient admitted in surgery department with features suggestive of extrahepatic biliary 
lithiasis. Baseline investigations, as routinely required, were done, followed by 
imaging studies. Patients were then explained about their disease process and the 
possible line of management. All the necessary information regarding the study was 
explained to the patients or their valid guardian. Informed written consent was taken 
from the patients or their guardian willing to participate in the study. Detailed history 
was taken from the study group to establish proper diagnosis. Thorough physical 
examination was done in each case. Data collection sheets were filled in by the 
investigator himself. All of the preoperative factors related to the patient were noted 
down in the data sheet. After proper evaluation and preparation, patients who required 
surgical management were taken up for surgery. Strict aseptic precautions were 
followed during the operation. Meticulous techniques were practiced as far as 
possible. The operation procedure and related per operative factors were observed 
directly and recorded in the data collection sheet instantly. After completing the 
collection of data it was compiled in a systematic way. 
 
3.8 Operational definitions: 
Cholelithiasis: a condition marked by presence of calculi in the gallbladder 
Choledocholithiasis: a condition marked by presence of calculi in the common 
bile duct 
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Hypothyroidism: abnormally low activity of the thyroid gland develops when the 
thyroid gland fails to produce or secrete as much thyroxine as the body needs. 
ERCP: (short for endoscopic retrograde cholangiopancreatography) is a procedure 
used to diagnose and treat diseases of the gallbladder, biliary system, pancreas, and 
liver. 
3.9 Variables Studied: 
Dependent variable: Hypothyroidism 
Independent variable: 
1. Age 
2. Sex 
3. Co- morbidities: Diabetes, obesity. 
4. USG findings 
5. Surgeries performed 
 
 
3.10 Ethical consideration 
                                    All the patients/ legal guardians were given an explanation of 
the study and about the investigative and operative procedures with their merits and 
demerits, expected results, and possible complications. If he/she agreed then the case 
had been selected for this study. The study did not involve any additional investigation 
or any significant risk. It did not cause economic burden to the patients. The study was 
approved by the institutional review board prior to commencement of data collection. 
Informed consent was taken from each patient/guardian. Data were collected by 
approved data collection form. 
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3.11 Data collection 
                                 Data were collected by pre-tested structured questionnaire. 
Data were collected from all the respondents by direct interview after getting 
informed written consent from them or from their legal guardian. 
3.12 Data analysis 
                           Data analysis was done both manually and by using 
computer. Calculated data were arranged in systemic manner, presented in 
various table and figures and statistical analysis was made to evaluate the 
objectives of this study with the help of Statistical Package for Social Science 
(SPSS). 
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     RESULTS 
                                  A prospective study was performed to determine the incidence of 
hypothyroidism in patients having cholelithiasis and choledocolthiasis. 68 patients 
were studied who fulfilled the inclusion criteria. All these patients were taken from the 
surgery department of Thanjavur Medical College, from 2014 June to 2015 August. 
All patients were evaluated clinically and only essential investigatons were performed 
before surgery, in addition patients underwent the thyroid function test. The results 
obtained are as follows. 
TABLE 1: Age distribution of patients with gall stone 
AGE/ SEX 
yrs 
          MALE        FEMALE           TOTAL 
    20-29               2               4               6 
    30-39               3             13             16 
    40-49               6             11             17 
     50-59              5              7              12 
     60-70              6             11              17 
    TOTAL            22(32.35%)              46(67.64%)             68 
 
     The mean age of patients with gall stones is 47.14 yrs. Male to female ratio is      1: 
2.2.  
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Table 2: Percentage of patient with co- morbidities 
 Co- Morbidity  Number Percentage 
Diabetes Mellitus 11 16 
Hypertension 14 20.5 
Both DM and HT 6 8 
No co morbidity 49 72.05 
 
Hypertension was the predominant co- morbidity in this study- in 20% of the patients. 
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Table 3: USG / CT findings of patients  
USG / CT Findings Number Percentage 
GB- Single stone 20 29.4 
GB- Multiple stones 46 67.64 
CBD Stones 5 27.3 
Both GB and CBD stone 3 4.4 
 
 
 
 
 
 
GB Multiple stones (67%)
GB Single stones (29.4%)
CBD Stones(7.3%)
Both(4.4%)
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Table 4: Management profile of gall stones 
Surgery Performed   Numbers    Percentage 
Open cholecystectomy 30 44.11 
Lap Cholecystectomy 36 52.94 
CBD exploration 4 5.8 
Conservative 2 2.9 
Lap Converted to open 4 5.8 
 
 
36 Patients underwent laparoscopic cholecystectomy out of which 4 patients were 
converted from lap to open procedure. 
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Table 5: Thyroid Profile of the patients 
 Numbers Percentage 
Hypothyroid 18 26.47 
Euthyroid 50 73.52 
                                     p value <0.05 and it is statiscally significant. 
26% of patients with cholelithiasis/ choledocolitiasis had hypothyroidism. 
 
   
p value is < 0.05 and it is statistically significant. 
 
74%
26%
Euthyroid Hypothyroid
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Table 6: Age and sex distribution of patients with hypothyroidism and gallstones/ 
CBD stones 
AGE/ SEX 
yrs 
MALE FEMALE 
20-29 0 3(4.4%) 
30-39 0 1(1.4%) 
40-49 0 1(1.4%) 
50-59 1(1.4%) 2(2.9%) 
60-70 3(4.4%) 7(10.2%) 
TOTAL 4(5.8%) 14(20.5%) 
(Figures in parentheses indicates percentages) 
 
 
Female sex and 50-70 yrs were the predominant group. More than 70% of the patients 
with hypothyroidism belong to this group. 
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Table 7: Image findings of patients with hypothyroidism 
USG Findings Numbers Percentage 
GB- Single stone 2 11.11 
GB- Multiple stones 14 77.77 
CBD stone 3 16.6 
Both 1 5.5 
Total 18 26.47 
 
 
Table 8: Management profile in gallstone patients with hypothyroidism 
Surgeries Performed Numbers Percentage 
Open Cholecystectomy 7 38.88 
Lap Cholecysyecyomy 7 38.88 
CBD exploration 3 16.66 
Lap to Open 0 0 
Conservative 1 5.5 
 
Both laparoscopic and open procedures were performed in hypothyroid patients.  
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                                         DISCUSSION 
                                      This prospective study was conducted 68 selected 
patients with evidence of cholelithiasis or choledocholithiasis in Department of 
General Surgery, Thanjavur Medical College. The study was carried out with a view 
to determine the prevalence of hypothyroidism in patients with extra hepatic biliary 
lithiasis in view of determining its importance as a causative factor and to include 
thyroid function tests as part of routine workup in gallstone patients. 
 
                                     Age of these selected patients ranged from 20- 70 yrs, with 
mean age being 47.14 yrs. 32% were male patients and 68% were female patients. The 
male to female ratio is 1: 2. Females were the predominant group. On analysing the 
co- morbid factors HT was the predominant co- morbid factor followed by Diabetes. 
HT was found to be a co- morbid factor in 14 patients (20%). DM was found to be a 
co- morbid factor in 11 (16%). 6 patients had both DM and HT. 
 
                                On evaluation of patients with USG and CT, 46 patients (67.4%) 
had multiple stones, and 20 patients (29.4%) had single stone. 5 patients had CBD 
stones and 3 patients had both CBD and GB stones. The size of the stones ranged 
from 4-18mm.  
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                             Patients were managed with both laparoscopic and open procedures. 
36 patients underwent laparoscopic cholecystectomy out of which 4 patients were 
converted from lap to open procedure. The reasons for conversion were bleeding, 
adhesions and technical difficulties. Open procedure was done in 30 patients and 4 
patients underwent CBD exploration in addition to cholecystectomy. 
 
                                 Thyroid function test was performed in all 68 patients out of 
which, 18 patients (26.4%) were found to have hypothyroidism and the rest i.e. 50  
patients were euthyroid. Of these 18 patients only 2 were known hypothyroid, rest 16 
patients were newly diagnosed hypothyroid patients. 
 
                                  Of these 18 patients, 16 patients were females rest were males. 
50-70 yrs were the predominant group. More than 70% of the patients with 
hypothyroidism belong to this group. 
 
                              Of all the hypothyroid patients, 14 had multiple stones and 4 had 
single stone, one patient had CBD stone and one patient had both CBD and GB stone. 
7 patients underwent open cholecystectomy and 7 underwent laparoscopic 
cholecystectomy. In 3 patients CBD exploration was done. Post operative and 
intraoperative periods were uneventful in all these patients. 
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                 LIMITATIONS OF THE STUDY 
As this study has been carried out over a limited period of time with a limited number 
of patients and there was lack of financial and infrastructural support, it could not 
have been large enough to be of reasonable precision. The follow up period was not 
long enough to comment about recurrence in patients with hypothyroidism and the 
response of the patients to thyroid medications.. All the facts and figures mentioned 
here may considerably vary from those of large series covering wide range of time, 
but still then, as the cases of this study were collected from a tertiary level hospital in 
our country, this study has some credentials in reflecting the facts regarding 
prevalence of hypothyroidism in gallstone patients and its possible correlation with 
the natural progression of the disease process. 
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                                                SUMMARY 
Cholelithiasis and Choledocholithiasis are one of the commonly encountered diseases 
in a general surgery department. Multiple risk factors have been attributed to the 
development of gallstones which include age, female gender, obesity, high fat diet, 
family history etc. Patients usually present with right hypochondrial pain, dyspepsia, 
vomiting and occasionally fever or jaundice. Management includes diagnostic 
imaging studies followed by surgery, if indicated. Hypothyroidism is not an accepted 
or proven risk factor for gallstones as of yet. Several studies have postulated the 
possible pathophysiology behind the role of thyroxine in the normal physiology of the 
biliary system. No concurrence has been established 
Age and Sex Distribution: 
The most commonly involved age group in patients with gall stones was 50 - 70, with 
incidence increasing with age. This correlates with the general literature that 
gallstones is a disease of the elderly. Female sex, is in itself a risk factor for 
developing gallstones with more than seventy five percent of the involved patients 
belonging to the female gender. 
Co Morbid Factors: 
 Hypertension and Diabetes Mellitus were the prevalent comorbid factors as 
cholelithiasis like previously told is a disease of the elderly.  None of these seemed to 
have a significant correlation with the disease process. 
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Diagnostic Studies: 
 USG was sensitive in detecting stones in nearly all patients with CECT abdomen and 
MRCP required only in few cases. 
Management: 
Laparoscopic and open  Cholecystectomy were both perfomed. Conversion to open 
was seen in 4 patients. This can be attributed to technical problems and as the study 
was done in a teaching institute and a good percentage of surgeries was done by 
trainees. 
Hypothyroidism and gallstones: 
Eighteen patients in our study had gallstones showing a prevalence of nearly one 
fourth of the patients being affected.  All these indicated a pathophysiological role of 
thyroxine in gallstone formation, apart from the supposed lipid metabolism 
abnormalities. This has been substantiated by physiological studies in animal models 
by Johanna Laukkarinen et al. 
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                                   CONCLUSION 
 This prospective ocservational type of study was conducted in Department of General 
Surgery, Thanjavur Medical College. It can be concluded from the findings of the 
study that hypothyroidism is a highly probable risk factor for development of 
hypothyroidism especially for middle aged females. Undetected and untreated 
hypothyroidism in such patients will result in persistence of the basic pathophysiology 
responsible for the initial disease process resulting in recurrence and complications. 
So, it can be assumed that patients at risk of forming gall stones due to 
hypothyroidism will benefit from early treatment. Most importantly, when treating 
patients with cholelithiasis or choledocholithiasis, clinicians should be aware of the 
possible hypothyroid background and consider examining the thyroid function, at least 
in female patients over 40 years of age, in which group the prevalence of clinical and 
subclinical hypothyroidism is the highest. 
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                     RECOMMENDATIONS 
On the basis of the findings of the study, the following recommendations can be 
made: 
1. Evaluation of thyroid profile should be a part of general workup in patients with 
both cholelithiasis and choledocholithiasis especially in female patients. 
2. Proper evaluation and preoperative preparation in patients with hypothyroidism, 
anticipating complications. 
3. The patients with clinical hypothyroidism should be started with appropriate thyroid 
medications. 
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                                           DATA COLLECTION CHART 
QUESTIONAIRE 
PATIENT DETAILS: 
Name:                                        Age:                             Sex: 
IP No. : 
ON ADMISSION: 
Main Complaints                                    : 
Symptoms of Gallstone/CBD stones      : 
H/o right upper quadrant pain                 : 
H/o vomiting                                           : 
H/o dyspepsia                                         : 
H/o fever                                                 : 
H/o jaundice                                            : 
Symptoms of Hypothyroidism                : 
H/o weight gain                                      : 
H/o weakness/ lethargy                           : 
H/o intolerance to cold                          : 
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H/o constipation                                    : 
H/o swelling of face or limbs                : 
H/o loss of hair / dry skin                      : 
Co – Morbid Illness                               : 
Significant Past History                         : 
 
CLINICAL EXAMINATION: 
Pulse:                                      BP:                             RR:                        Temp: 
Pallor:                                      Icterus: 
CVS:                                        RS: 
P/A: 
Thyroid examination: 
INVESTIGATIONS: 
Hemogram: Renal Function Test: 
Liver Function Test: 
BT/CT:                                    Blood Grouping:            Fasting Lipid Profile: 
ECG:                                      CXR: 
USG Abdomen: 
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Thyroid profile: T3 --                         T4 --                    TSH — 
Operative Procedure: 
FOLLOW UP: 
 
 
 
     
S.No Name Age Sex Ip No.
LFT TFT USG Abdomen/ CT
Procedure Remarks
TSH T3 (pg/ml) T4 (mcg/dl) Size largest CBD stone
1 Chinnathambi 50 Male 33790 No DM Normal 1.2/0.7 4.5 2.5 2 Multiple 6mm Normal Open Chole
2 Krishnamoorthy 35 Male 34023 No - Normal 0.9/0.3 3.5 1.6 4 Multiple 5mm Normal Open Chole
3 Segappi 65 Female 33560 No - Normal 1.1/0.4 5 2.8 5.5 Single 9mm Normal Lap Chole
4 Krishnaveni 30 Female 34034 No - Normal 1.2/0.5 4.6 3.9 6.5 Multiple 5mm Normal Lap to open 
5 Govindasamy 70 Male 40756 No - Normal 2.5/1.2 1.5 2.7 9 Multiple Normal Conservative
6 Shanthi 36 Female 40371 No - Normal 0.9/0.4 8.5 2.4 4 Multiple 7mm Normal Open Chole
7 Jothika 20 Female 38909 No - Normal 1.2/0.5 > 16 0.4 0.9 Multiple 6mm Normal Lap Chole Hypothyroid
8 Bangaru 55 Female 41027 No DM Normal 1.4/0.5 5.5 2.6 5 Single 8mm Normal Lap Chole
9 Thilagavathy 30 Female 39123 No Normal 1.2/0.6 3 3.8 5.5 Single 7mm Normal Lap Chole
10 Shenbagavalli 55 Female 39563 No - Normal 1.1/0.6 1.5 4.5 8 Multiple 18mm Normal Lap to open 
11 Pichaiammal 68 Female 39845 No DM Normal 1.1/0.5 >12 3.4 4.5 Multiple 8mm Normal Open Chole Hypothyroid
12 Chitra 43 Female 35421 No - Normal 1.2/0.5 4.5 2.5 3 Multiple 5mm Normal Open Chole
13 Subramani 45 Male 37019 No - Normal 1.1/0.4 4 3.3 5.5 Single 8mm Normal Open Chole
14 Anbumani 64 Female 37131 No - Normal 1.4/0.6 >20 0.6 4.2 Multiple 4mm Normal Lap Chole Hypothyroid
15 Venmathy 48 Female 38939 No HT Normal 1.2/0.6 4 2.7 8 Single 7mm Normal Lap Chole
16 Ganesh 63 Male 38741 No - Normal 1.2/0.6 5.5 3.6 7 Single 5mm Normal Lap to open 
17 Pankajavalli 50 Female 38666 No - Normal 1.8/0.8 >16 1.6 0.8 Multiple 8mm Normal Lap Chole Hypothyroid
18 Saraswathy 70 Female 38995 No HT/DM Normal 2.0/0.8 >18 1.8 2 Multiple 12mm Normal Open Chole Hypothyroid
19 Thanapal 45 Male 35415 No HT Normal 1.2/0.5 4 3.2 5.8 Multiple 5mm Normal Lap Chole
20 Murali 24 Male 36422 No - Normal 1.4/0.5 5.5 4.1 8 Single 5mm Normal Lap Chole
21 Krishnamoorthy 35 Male 34545 No HT Normal 2.0/1 5 3.7 7.8 Multiple 6mm Normal Open Chole
22 Mani 45 Female 37845 No - Normal 1.5/0.6 4 2.5 9.2 Single 8mm Normal Lap Chole
23 Selvi 35 Female 36261 No - Normal 1.4/0.5 5.2 3.6 8 Multiple 7mm Normal Lap chole
24 Saralmary 20 Female 37121 No - Normal 1.0/0.4 >12 0.2 0.6 Multiple 6mm Normal Lap Chole Hypothyroid
25 Mary 50 Female 32151 No Normal 1.2/0.6 >80 1.2 0.4 Multiple 8mm 6mm Conservative Hypothyroid
26 Rajendran 52 Male 35020 No Normal 1.6/0.5 >20 0.5 0.3 Multiple 8mm Normal Open Chole Hypothyroid
27 Vennila 56 Female 34102 No DM Normal 1.5/0.6 4.5 3.2 6 Multiple 6mm Normal Lap Chole
28 Vaduvambaal 45 Female 34523 No - Normal 1.2/0.6 4.2 3.2 7 Single 5mm Normal Lap Chole
29 Indrani 60 Female 32012 Yes - Normal 2.6/1.2 >15 2.4 0.8 8mm Hypothyroid
30 Chitra 34 Female 42587 No - Normal 1.2/0.5 4.2 2.2 9 Multiple 7mm Normal Lap Chole
31 Nageshwaran 55 Male 42310 No HT Normal 1.0/0.3 5 2.6 7 Single 8mm Normal Lap Chole
32 Nandhini 35 Female 42014 No - Normal 0.9/0.4 3.5 3.4 8.6 Single 8mm Normal Lap chole
33 Kamalam 60 Female 32003 No DM/HT Normal 1.2/0.6 3 2.4 8.2 Multiple 5mm Normal Open Chole
34 Hansiya 28 Female 45110 No - Goitre 1.1/0.6 >20 2.2 1.2 Multiple 6mm Normal Lap Chole Hypothyroid
35 Sudha 36 Female 42201 No - Normal 2.0/1.0 5 3.5 7.9 Multiple 5mm Normal Lap Chole
36 Sumathy 38 Female 35023 No - Normal 1.6/0.6 4.5 4.2 7.4 5mm
37 Arul Mary 40 Female 34152 No - Normal 1.2/0.6 4.6 3.2 8.8 Multiple 7mm Normal Open Chole
38 Thilagavathy 30 Female 48574 No - Normal 1.5/0.6 4.6 2.4 10 Multiple 8mm Normal Lap Chole
39 Veerasamy 65 Male 47152 No DM/HT Normal 1.8/0.8 >20 3.5 2 Multiple 6mm Normal Open Chole Hypothyroid
40 Vasuki 43 Female 35022 No - Normal 1.0/0.3 2.5 4.2 8.8 Single 8mm Normal Lap Chole
41 Saraswathy 60 Female 35102 No - Normal 1.6/0.6 >30 0.6 2 Multiple 6mm Normal Open Chole Hypothyroid
42 Mala 35 Female 36201 No - Normal 1.2/0.6 4.5 2.6 11  Multiple 8mm Normal Lap Chole
43 Kaliammal 53 Female 35016 No - Normal 1.6/0.4 5.5 3.6 9.6 Multiple 7mm Normal Lap Chole
44 Balasubramanian 49 Male 36001 No - Normal 2/0.8 4.5 3.4 7.4 Multiple 6mm Normal Lap Chole
45 Pitchai 66 Male 45006 No DM/HT Normal 1.6/0.5 >15 0.4 2 Multiple 7mm Normal Open Chole Hypothyroid
46 Amutha 40 Female 35465 No - Normal 1.6/0.4 4.5 2.5 9.4 Multiple 9mm Normal Lap Chole
47 Raja 44 Male 45102 No - Normal 1.8/0.6 5 3 7.3 Single 6mm Normal Lap Chole
48 Krishnaleela 35 Female 45181 No - Normal 2.4/0.8 4.5 2 8.4 Multiple 8mm Normal Lap Chole
49 Pichaiammal 65 Female 38695 No - Normal 1.8/0.6 5 2.2 9.4 Multiple 7mm Normal Lap Chole
50 Malar 34 Female 36558 No - Normal 1.3/0.6 4.6 2 7 Multiple 5mm Normal Lap to open 
51 Vellaiyammal 21 Female 38891 No - Normal 1.6/0.6 5.5 2.1 8.4 Single 8mm Normal Lap Chole
52 Peter 52 Male 33161 No HT nNormal 1.6/0.5 5.5 3.6 8.2 Multiple 5mm Normal Lap Chole
53 Hyarunisha 60 Female 33406 No HT Normal 2.5/1.2 >30 3.2 2.6 Multiple 6mm 6mm Hypothyroid
54 Ponnusamy 62 Male 45545 No Normal 2.6/0.6 5.5 3 8.8 Multiple 5mm Normal Open Chole
55 Sivakumar 38 Male 46335 No HT Normal 1.6/0.6 2.5 2.8 7.8 Multiple 4mm Normal Open Chole
56 Manikandan 21 Male 49987 No - Normal 3.2/0.7 3.5 2.6 8.8 Single 7mm Normal Lap to open 
57 Kannan 45 Male 50024 No - Normal 1.8/0.5 5.5 3.7 8.9 Single 6mm Normal Lap Chole
58 Abdul Latif 60 Male 33387 No DM/HT Normal 2.0/0.8 >20 1.2 3.8 Single 7mm Normal Lap Chole Hypothyroid
59 Shanmugavalli 42 Female 38845 No - MNormal 2.6/0.8 5 41 9 Multiple 8mm Normal Lap Chole
60 Bhuvaneshwari 45 Female 58168 No - Normal 2.2/1.6 20.5 0.6 2.2 Multiple 10mm Normal Lap Chole Hypothyroid
61 Malarkodi 45 Female 45012 No - Normal 1.6/0.4 4.2 0.8 8 Single 6mm Normal Lap Chole
62 Manimegam 56 Male 58774 No Normal 2/0.9 5 2.2 9.5 Multiple 5mm Normal Open Chole
63 Kumaresan 47 Male 47587 No Normal 1.2/0.6 4 2.6 7.4 Multiple 7mm Normal Lap Chole
64 Muthulakshmi 36 Female 45645 No - Normal 3.5/1.2 >20 0.6 1.2 Multiple 6mm 5mm Hypothyroid
65 Umarani 45 Female 36521 No DM Normal 1.2/0.6 4.5 4.2 7.4 Multiple 4mm Normal Lap Chole
66 Seetha 56 Female 25412 No HT Normal 1/0.4 1.5 2.6 8.8 Single 7mm Normal Open Chole
67 Govindaraj 70 Female 48725 No HT,DM Normal 2.5/1.2 13.5 2.6 3.3 Single 8mm Normal Open Chole Hypothyroid
68 Munniyammal 66 Female 36586 No - Normal 1/0.3 1.8 2.9 9.8 Multiple 6mm Normal Lap chole
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ABSTRACT 
 
TITLE: Association of Cholelithiasis, Choledocholithiasis 
And Hypothyroidism 
INTRODUCTION:Thyroid disorder is a prevalent condition among adult 
population; however, it is frequently over looked.. Hypothyroidism causes low bile 
flow and sphincter of Oddi dysfunction and hence promotes gall stone formation. This 
study was done to substantiate the need for evaluating the thyroid status in patients 
presenting with cholelithiasis/ choledocholithiasis. 
 
AIMS:  To study the prevalence of hypothyroidism in patients presenting with 
CHOLELITHIASIS/ CHOLEDHOCOLITHIASIS.To assess if thyroid profile is 
indicated in patients with biliary lithiasis. 
 
MATERIALS AND METHODS: This is an observational and prospective study. 
Method of sampling was non-random, purposive. 68 patients with USG evidence of 
cholelithiasis/ choledocholilithiasis, were evaluated with basic investigations and 
additionally thyroid function test was performed. The operation procedure and related 
per operative factors were observed directly and recorded. 
 
RESULTS: The operation procedure and related per operative factors were observed 
directly and recorded in the data collection sheet instantly. Age of these selected 
patients ranged from 20- 70 yrs, with mean age being 47.14 yrs. 32% were male 
patients and 68% were female patients. The male to female ratio is 1: 2. Females were 
the predominant group. Thyroid function test was performed in all 68 patients out of 
which, 18 patients (26.4%) were found to have hypothyroidism and the rest i.e. 50  
patients were euthyroid. Of these 18 patients only 2 were known hypothyroid, rest 16 
patients were newly diagnosed hypothyroid patients .Of these 18 patients, 16 patients 
were females rest were males. 50-70 yrs were the predominant group. More than 70% 
of the patients with hypothyroidism belong to this group.  
 
CONCLUSION:  Evaluation of thyroid profile should be a part of general workup in 
patients with both cholelithiasis and choledocholithiasis especially in females above 
the age of 40yrs and patient should be treated with appropriate thyroid medications. 
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